A study of extradural medication in the relief of the lumbosciatic syndrome

M. Swerdlow,Sayle-Creer Ws

DOI: https://doi.org/10.1111/j.1365-2044.1970.tb00218.x

IF: 12.893

1970-09-01

Anaesthesia

Abstract:The use of extradural injections to relieve backache has been the subject of a number of studies in recent years. The idea is not a new one; as long ago as 1901 Sicardl employed extradural cocaine by the caudal route to treat three cases of lumbago and four of sciatica-'recovery was maintained for 14 days'. In 1925 Vinerz published a small series of cases in whom sciatica was treated by caudal extradural injection of 2Oml 1 % procaine followed by 50-1oOml Ringers solution, normal saline or liquid petrolatum. In 1930 Evans3 reported on the use of sacral extradural injection of 60-8Oml normal saline or procaine in 40 patients; he claimed that the condition was improved in 14%. Many further reports of encouraging results following the administration of extradural saline and/or local analgesic have been published,4-8. The use of steroid preparations by the extradural route was first employed in 1953 by Lievreg and in 1961 Goebert et al. 10 reported a series of 113 patients with painful radiculopathy treated with epidural procaine and hydrocortisone acetate. Since then a number of similar series have been published which c o n m the value of the method11-14. The present study was carried out in the SaIford Group of Hospitals over the ten year period (mid-I958 to mid-1968). Of a total of over 5,000 patients complaining of backache 530 considered to be suffering from the lumbosciatic syndrome were treated by extradural injection of either normal saline, local analgesic or methyl-prednisolone acetate (Depomedrone). In the earlier years of the study the former two agents only were employed. They were given either by the lumbar or the caudal route and in random order. Since 1963 we have used methylprednisolone exclusively, and this has always been injected into the lumbar extradural space. All the 325 patients included in this report have been followed up for at least 12 months.